FdaApplication
ANDA 091226
Identifiers
- fda_app_no: ANDA091226
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2012-05-29 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET;ORAL |
4 products